Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Methotrexate market in this environment.
In terms of revenue, this research report indicated that the global Methotrexate market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Methotrexate industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The ????Teva Pharmaceutical aims at producing XX Methotrexate in 2020, with XX % production to take place in global market, ????Qualitestrx accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Methotrexate Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Methotrexate Market?
Teva Pharmaceutical
Qualitestrx
Pfizer(Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan
Powerdone
Huiyu
...
Major Type of Methotrexate Covered in XYZResearch report:
Tablet
Injection
Application Segments Covered in XYZResearch Market
Used for breast, head and neck, lung, stomach, and esophagus cancers
Used for acute lymphoblastic leukemia, sarcomas, non-Hodgkin's lymphoma
Used for rheumatoid arthritis
Used for other diseases
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Methotrexate Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Tablet -Product Introduction and Major Manufacturers
1.1.2 Injection -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Methotrexate Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Methotrexate Market
3.1.1 Top Companies leading Methotrexate Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Methotrexate Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Methotrexate Market
3.2.1 Top Companies leading Methotrexate Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Methotrexate Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Methotrexate Market
3.3.1 Top Companies leading Methotrexate Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Methotrexate Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Methotrexate Market
3.4.1 Top Companies leading Methotrexate Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Methotrexate Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Methotrexate Market
3.5.1 Top Companies leading Methotrexate Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Methotrexate Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Methotrexate Market
3.6.1 Top Companies leading Methotrexate Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Methotrexate Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Methotrexate Market
3.7.1 Top Companies leading Methotrexate Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Methotrexate Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Methotrexate Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Methotrexate Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Methotrexate Sales and Growth Rate (2021-2026)
5.2 Global Methotrexate Sales Value and Growth Rate (2021-2026)
6 Methotrexate Competitive Analysis
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Company Profiles
6.1.2 Teva Pharmaceutical Product Introduction
6.1.3 Teva Pharmaceutical Methotrexate Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Qualitestrx
6.2.1 Qualitestrx Company Profiles
6.2.2 Qualitestrx Product Introduction
6.2.3 Qualitestrx Methotrexate Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Pfizer(Hospira)
6.3.1 Pfizer(Hospira) Company Profiles
6.3.2 Pfizer(Hospira) Product Introduction
6.3.3 Pfizer(Hospira) Methotrexate Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Roxane Laboratories
6.4.1 Roxane Laboratories Company Profiles
6.4.2 Roxane Laboratories Product Introduction
6.4.3 Roxane Laboratories Methotrexate Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Sine
6.5.1 Sine Company Profiles
6.5.2 Sine Product Introduction
6.5.3 Sine Methotrexate Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Maoxiang
6.6.1 Maoxiang Company Profiles
6.6.2 Maoxiang Product Introduction
6.6.3 Maoxiang Methotrexate Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 LingNan
6.7.1 LingNan Company Profiles
6.7.2 LingNan Product Introduction
6.7.3 LingNan Methotrexate Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Powerdone
6.8.1 Powerdone Company Profiles
6.8.2 Powerdone Product Introduction
6.8.3 Powerdone Methotrexate Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Huiyu
6.9.1 Huiyu Company Profiles
6.9.2 Huiyu Product Introduction
6.9.3 Huiyu Methotrexate Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
7 Conclusion
The global Methotrexate Sodium market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Methotrexate market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field e...
The global Methotrexate Oral Solution Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...
The global Methotrexate Oral Solution market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Methotrexate Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...
The global Methotrexate Sodium market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
Summary
The global Methotrexate Oral Solution market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors inf...
Summary
The global Methotrexate market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing marke...
Summary
The global Methotrexate Drugs market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing...
Overview of the Global Methotrexate Market:
The report discusses everything a marketer requires before investing in the global Methotrexate Market during the forecast period 2021-2028. It provides detailed insight i...